Evidence map›Paper›PMID 38524774›Full record

ArticleHealth science reports2024

Molecular and phylogenetic characterization of the monkeypox outbreak in the South of Spain.

Carlos S Casimiro-Soriguer, Javier Perez-Florido, Maria Lara, Pedro Camacho-Martinez, Laura Merino-Diaz, Inmaculada Pupo-Ledo, Adolfo de Salazar, Ana Fuentes, Laura Viñuela, Natalia Chueca and 5 more

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Carlos S Casimiro-SoriguerComputational Medicine Platform, Andalusian Public Foundation Progress and Health-FPS Sevilla Spain.
Javier Perez-FloridoComputational Medicine Platform, Andalusian Public Foundation Progress and Health-FPS Sevilla Spain.
Maria LaraComputational Medicine Platform, Andalusian Public Foundation Progress and Health-FPS Sevilla Spain.
Pedro Camacho-MartinezServicio de Microbiología, Unidad Clínica Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío Sevilla Spain.
Laura Merino-DiazServicio de Microbiología, Unidad Clínica Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío Sevilla Spain.
Inmaculada Pupo-LedoServicio de Microbiología, Unidad Clínica Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen del Rocío Sevilla Spain.
Adolfo de SalazarCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), ISCIII Madrid Spain.
Ana FuentesCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), ISCIII Madrid Spain.
Laura ViñuelaCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), ISCIII Madrid Spain.
Natalia ChuecaCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), ISCIII Madrid Spain.
Luis Martinez-MartinezCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), ISCIII Madrid Spain.
Nicola LorussoDirección General de Salud Pública, Consejería de Salud y Familias, Junta de Andalucía Sevilla Spain.
Jose A LepeInstitute of Biomedicine of Seville, IBiS, University Hospital Virgen del Rocío/CSIC/University of Seville Seville Spain.
Joaquín DopazoComputational Medicine Platform, Andalusian Public Foundation Progress and Health-FPS Sevilla Spain.ORCID https://orcid.org/0000-0003-3318-120X
Federico GarciaCentro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), ISCIII Madrid Spain.
Instituto de Salud Carlos III · ESFundación Progreso y Salud · ESHospital Universitario Virgen del Rocío · ESConsejería de Salud y Consumo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Until the May 2022 Monkeypox (MPXV) outbreak, which spread rapidly to many non-endemic countries, the virus was considered a viral zoonosis limited to some African countries. The Andalusian circuit of genomic surveillance was rapidly applied to characterize the MPXV outbreak in the South of Spain. Methods: Whole genome sequencing was used to obtain the genomic profiles of samples collected across the south of Spain, representative of all the provinces of Andalusia. Phylogenetic analysis was used to study the relationship of the isolates and the available sequences of the 2022 outbreak. Results: Whole genome sequencing of a total of 160 MPXV viruses from the different provinces that reported cases were obtained. Interestingly, we report the sequences of MPXV viruses obtained from two patients who died. While one of the isolates bore no noteworthy mutations that explain a potential heightened virulence, in another patient the second consecutive genome sequence, performed after the administration of tecovirimat, uncovered a mutation within the A0A7H0DN30 gene, known to be a prime target for tecovirimat in its Vaccinia counterpart. In general, a low number of mutations were observed in the sequences reported, which were very similar to the reference of the 2022 outbreak (OX044336), as expected from a DNA virus. The samples likely correspond to several introductions of the circulating MPXV viruses from the last outbreak. The virus sequenced from one of the two patients that died presented a mutation in a gene that bears potential connections to drug resistance. This mutation was absent in the initial sequencing before treatment.

Indexed as

drug resistancegenomic surveillancemonkeypoxoutbreakwhole genome sequencing

Identifiers

PMID38524774
PMCPMC10957719
OpenAlexW4393091586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.